Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 4/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.47 |
| ▸ | GABRR1 | P24046 | 5/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17336867 | 1.00 | SLC1A2 (0.47) | SLC1A2SLC1A1GABRR1HSD11B1GABRR2 | |
| SCHEMBL6829616 | 0.80 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL14118112 | 0.78 | SLC1A2 (0.40) | SLC1A2SLC1A1GABRR1HSD11B1KMT2A | |
| SCHEMBL8995147 | 0.78 | SLC1A2 (0.47) | SLC1A2SLC1A1GABRR1GABRR2MEN1 | |
| SCHEMBL10557954 | 0.78 | SLC1A2 (0.47) | SLC1A2SLC1A1GABRR1GABRR2MEN1 | |
| SCHEMBL13020532 | 0.77 | SLC1A2 (0.47) | SLC1A2SLC1A1GABRR1GABRR2MEN1 | |
| SCHEMBL14123456 | 0.77 | SLC1A2 (0.39) | SLC1A2SLC1A1GABRR1HSD11B1 | |
| SCHEMBL3270629 | 0.77 | — | — | |
| SCHEMBL24425352 | 0.76 | POLB (0.39) | SLC1A2SLC1A1KMT2ACYP2C19 | |
| SCHEMBL14653071 | 0.76 | POLB (0.39) | SLC1A2SLC1A1KMT2ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12013523-B2 | Immersion oils having long service life | CARL ZEISS JENA GMBH (DE) | 2024-06-18 | — | — | US | claimed |
| US-12013523-B2 | Immersion oils having long service life | CARL ZEISS JENA GMBH (DE) | 2024-06-18 | — | — | US | disclosed |
| US-20210302712-A1 | Immersion oils having long service life | CARL ZEISS JENA GMBH (DE) | 2021-09-30 | — | — | US | disclosed |
| US-20080206668-A1 | NEGATIVE RESIST COMPOSITION AND PATTERN FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-08-28 | — | — | US | disclosed |
| EP-0897747-B1 | NITRATION OR CARBOXYLATION CATALYSTS | DAICEL CHEM (JP) | 2006-04-05 | — | — | EP | disclosed |
| EP-1574495-A1 | Adamantane derivatives | Daicel Chemical Industries, Ltd. (JP) | 2005-09-14 | — | — | EP | disclosed |
| EP-1574494-A1 | Adamantane derivative | Daicel Chemical Industries, Ltd. (JP) | 2005-09-14 | — | — | EP | disclosed |
| US-6468487-B1 | SUCH AS N-HYDROXYPHTHALIMIDE; DIRECTLY AND EFFICIENTLY REACTING ADAMANTANE WITH NITROGEN OXIDE OR WITH CARBON MONOXIDE AND OXYGEN | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-0897747-A1 | NITRATION OR CARBOXYLATION CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 1999-02-24 | — | — | EP | disclosed |
| EP-0171847-B1 | LIQUID, CURABLE COATING COMPOSITION BASED ON A HYDROXYL GROUPS-CONTAINING ADDITION POLYMER AS BINDER | AKZO N.V. (NL) | 1988-06-01 | — | — | EP | disclosed |
| EP-0171847-A1 | Liquid, curable coating composition based on a hydroxyl groups-containing addition polymer as binder | AKZO N.V. (NL) | 1986-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12013523-B2 | Immersion oils having long service life | DGKI, CCNE2, CYCS | SLC1A2 4742/4885SLC1A1 4865/4885GABRR1 4834/4885 |
| US-20210302712-A1 | Immersion oils having long service life | DGKI, CCNE2, CYCS | SLC1A2 4742/4885SLC1A1 4865/4885GABRR1 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.